- Home
- MNOV vs DPRO Comparison
MNOV vs DPRO Comparison
Compare MNOV & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- DPRO
- Stock Information
- Founded
- MNOV 2000
- DPRO 1998
- Country
- MNOV United States
- DPRO Canada
- Employees
- MNOV N/A
- DPRO N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- DPRO Aerospace
- Sector
- MNOV Health Care
- DPRO Industrials
- Exchange
- MNOV Nasdaq
- DPRO Nasdaq
- Market Cap
- MNOV 68.2M
- DPRO 81.2M
- IPO Year
- MNOV 2005
- DPRO N/A
- Fundamental
- Price
- MNOV $1.34
- DPRO $4.96
- Analyst Decision
- MNOV Strong Buy
- DPRO Strong Buy
- Analyst Count
- MNOV 2
- DPRO 2
- Target Price
- MNOV $7.00
- DPRO $6.50
- AVG Volume (30 Days)
- MNOV 62.5K
- DPRO 1.7M
- Earning Date
- MNOV 08-14-2025
- DPRO 08-11-2025
- Dividend Yield
- MNOV N/A
- DPRO N/A
- EPS Growth
- MNOV N/A
- DPRO N/A
- EPS
- MNOV N/A
- DPRO N/A
- Revenue
- MNOV $134,599.00
- DPRO $5,250,872.00
- Revenue This Year
- MNOV N/A
- DPRO $69.58
- Revenue Next Year
- MNOV N/A
- DPRO $100.68
- P/E Ratio
- MNOV N/A
- DPRO N/A
- Revenue Growth
- MNOV N/A
- DPRO 17.08
- 52 Week Low
- MNOV $1.13
- DPRO $1.55
- 52 Week High
- MNOV $2.55
- DPRO $7.31
- Technical
- Relative Strength Index (RSI)
- MNOV 52.82
- DPRO 58.27
- Support Level
- MNOV $1.32
- DPRO $3.85
- Resistance Level
- MNOV $1.43
- DPRO $4.55
- Average True Range (ATR)
- MNOV 0.04
- DPRO 0.33
- MACD
- MNOV 0.00
- DPRO 0.04
- Stochastic Oscillator
- MNOV 50.00
- DPRO 91.55
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.